Metropolitan Life Insurance Company (MetLife)’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,950
| Closed | -$68.2K | – | 2307 |
|
|
2024
Q1 | $68.2K | Hold |
1,950
| – | – | ﹤0.01% | 1252 |
|
|
2023
Q4 | $74.1K | Hold |
1,950
| – | – | ﹤0.01% | 1239 |
|
|
2023
Q3 | $35.8K | Buy |
1,950
+140
| +8% | +$2.57K | ﹤0.01% | 1581 |
|
|
2023
Q2 | $47K | Hold |
1,810
| – | – | ﹤0.01% | 1458 |
|
|
2023
Q1 | $34.2K | Sell |
1,810
-272
| -13% | -$5.13K | ﹤0.01% | 1602 |
|
|
2022
Q4 | $51.3K | Hold |
2,082
| – | – | ﹤0.01% | 1459 |
|
|
2022
Q3 | $37.4K | Hold |
2,082
| – | – | ﹤0.01% | 1654 |
|
|
2022
Q2 | $23.6K | Hold |
2,082
| – | – | ﹤0.01% | 1962 |
|
|
2022
Q1 | $46.4K | Sell |
2,082
-5,704
| -73% | -$127K | ﹤0.01% | 1644 |
|
|
2021
Q4 | $340K | Sell |
7,786
-1,036
| -12% | -$45.2K | ﹤0.01% | 1669 |
|
|
2021
Q3 | $294K | Hold |
8,822
| – | – | ﹤0.01% | 1785 |
|
|
2021
Q2 | $243K | Buy |
+8,822
| New | +$243K | ﹤0.01% | 2010 |
|
|
2021
Q1 | – | Sell |
-2,769
| Closed | -$91.3K | – | 2631 |
|
|
2020
Q4 | $91.3K | Buy |
+2,769
| New | +$91.3K | ﹤0.01% | 2396 |
|